Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.093
Buy
RSI(14)
57.812
Neutral
STOCH(KDJ)(9,3,3)
62.885
Sell
ATR(14)
0.372
Low Volatility
CCI(14)
82.265
Neutral
Williams %R
39.560
Buy
TRIX(12,20)
0.633
Sell
StochRSI(14)
0.000
Sell
Search
Sophia Genetics SA
SOPHAdd to Watchlist
6.040USD
-0.360-5.63%
Close 07-23 16:00（ET）Quotes delayed by 15 min
433.61MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-5.63%
5 Days
+3.60%
1 Month
+15.49%
6 Months
+12.69%
Year to Date
+29.34%
1 Year
+67.31%
Key Figures
6.350Open
6.520High
392.03KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.55%Turnover Ratio
6.400Prev. Close
6.030Low
1.87MTurnover
LossP/E Static
9.49P/B
0.00%Div Yield TTM
-53.30%ROA
5.70052wk High
0.90Volume Ratio
-62.49MNet Profit
71.79MShares
-1.1812EPS TTM
0.99Beta
-123.28%ROE
2.59052wk Low
7.66%Amplitude
68.01%Gross Margin
433.61MMarket Cap
3.80Reward/Risk
4.19%Risk Rate
TradingKey Stock Score of Sophia Genetics SA
Currency: USD Updated: 2026-07-23Key Insights
Sophia Genetics SA's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 134 out of 485 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.00.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sophia Genetics SA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Sophia Genetics SA Highlights
StrengthsRisks
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 23.89% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 77.27M.
Undervalued
The company’s latest PE is -5.12, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 27.73M shares, decreasing 30.02% quarter-over-quarter.
Held by Akre Capital Management
Star Investor Akre Capital Management holds 3.62M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.40.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
9.000
Target Price
+38.46%
Upside Space
Sophia Genetics SA News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
6.230
Sell
MA10
5.980
Buy
MA20
5.802
Buy
MA50
5.326
Buy
MA100
5.103
Buy
MA200
4.904
Buy
Sophia Genetics SA Info
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Ticker SymbolSOPH
CompanySophia Genetics SA
CEOCamblong (Jurgi)
Websitehttps://www.sophiagenetics.com/
Related Instruments
-5.47%
-7.12%
-6.90%
-2.25%
-3.37%
-0.51%
-0.32%
-4.60%
-0.97%
+0.49%
-2.88%
-2.14%
+0.38%
-2.64%
-1.63%
-1.98%
-3.30%
-3.71%
-0.37%
-2.29%Popular Instruments
51978.200
+254.200 (+0.49%)
28506.300
-71.700 (-0.25%)
7427.100
+7.200 (+0.10%)
14985.000
-116.000 (-0.77%)
64997.000
-374.000 (-0.57%)
6253.700
+38.000 (+0.61%)
89.263
-2.849 (-3.09%)
321.680
-4.210 (-1.29%)
208.770
-3.290 (-1.55%)
4060.460
+11.090 (+0.27%)
FAQs
What is the current price of Sophia Genetics SA (SOPH)?
The current price of Sophia Genetics SA (SOPH) is 6.04.
What is the symbol of Sophia Genetics SA?
The ticker symbol of Sophia Genetics SA is SOPH.
What is the 52-week high of Sophia Genetics SA?
The 52-week high of Sophia Genetics SA is 5.70.
What is the 52-week low of Sophia Genetics SA?
The 52-week low of Sophia Genetics SA is 2.59.
What is the market capitalization of Sophia Genetics SA?
The market capitalization of Sophia Genetics SA is 433.61M.
Is Sophia Genetics SA (SOPH) currently rated as Buy, Hold, or Sell?
According to analysts, Sophia Genetics SA (SOPH) has an overall rating of Buy, with a price target of 9.00.
What is the Earnings Per Share (EPS TTM) of Sophia Genetics SA (SOPH)?
The Earnings Per Share (EPS TTM) of Sophia Genetics SA (SOPH) is -1.17.